ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,517.97
      0.16%
      US Tech 100
      19,493.20
      0.07%
      Dow Jones
      39,336.14
      0.01%
      Brent Oil
      86.445
      0.00%
      Bitcoin
      60,452.07
      -2.54%
      Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ

      6. Astria Therapeutics Inc (ATXS) Quote

      Astria Therapeutics Inc

      Astria Therapeutics Inc (ATXS)

      NASDAQ
      9.01
      0.04
      ( 0.45% )
      Updated: 10:03:05
      Delayed by 15 minutes

      Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

      Premium

      Key stats and details

      Current Price
      9.01
      Bid
      9.01
      Ask
      9.09
      Volume
      11,453
      8.94 Day's Range 9.09
      4.26 52 Week Range 16.90
      Market Cap
      468.958M
      Previous Close
      8.97
      Open
      9.00
      Last Trade
      28
      @
      9.0543
      Last Trade Time
      10:03:39
      Financial Volume
      $ 103,209
      VWAP
      9.0115
      Average Volume (3m)
      605,038
      Shares Outstanding
      54,913,061
      Dividend Yield
      -
      PE Ratio
      -6.43
      Earnings Per Share (EPS)
      -1.33
      Revenue
      -
      Net Profit
      -72.89M

      About Astria Therapeutics Inc

      Astria Therapeutics Inc is a biopharmaceutical company engaged to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases. Its lead program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in preclinical development for... Astria Therapeutics Inc is a biopharmaceutical company engaged to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases. Its lead program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in preclinical development for the treatment of hereditary angioedema. Show more

      Sector
      Pharmaceutical Preparations
      Industry
      Pharmaceutical Preparations
      Website
      www.astriatx.com
      Headquarters
      Wilmington, Delaware, USA
      Founded
      1970
      Astria Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker ATXS. The last closing price for Astria Therapeutics was $8.97. Over the last year, Astria Therapeutics shares have traded in a share price range of $ 4.26 to $ 16.90.

      Astria Therapeutics currently has 54,913,061 shares outstanding. The market capitalization of Astria Therapeutics is $468.96 million. Astria Therapeutics has a price to earnings ratio (PE ratio) of -6.43.

      ATXS Latest News

      More News

      FeaturedFreedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent

      1 hour ago

      Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

      Astria Therapeutics, Inc. (Nasdaq:ATXS), a biopharmaceutical company focused on developing life-changing therapies for allergic and immunological diseases, granted stock options to purchase...

      18 hours ago
      Business Wire

      Form 4 - Statement of changes in beneficial ownership of securities

      June 06 2024
      Edgar (US Regulatory)

      Form 4 - Statement of changes in beneficial ownership of securities

      June 06 2024
      Edgar (US Regulatory)

      Form 4 - Statement of changes in beneficial ownership of securities

      June 06 2024
      Edgar (US Regulatory)

      Form 4 - Statement of changes in beneficial ownership of securities

      June 06 2024
      Edgar (US Regulatory)

      Form 8-K - Current report

      June 06 2024
      Edgar (US Regulatory)

      Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

      Astria Therapeutics, Inc. (Nasdaq:ATXS), a biopharmaceutical company focused on developing life-changing therapies for allergic and immunological diseases, granted stock options to purchase...

      June 04 2024
      Business Wire

      Astria Therapeutics to Present at Upcoming Jefferies Healthcare Conference

      Astria Therapeutics, Inc. (NASDAQ:ATXS), a biopharmaceutical company focused on developing life-changing therapies for allergic and immunological diseases, today announced that Jill C. Milne...

      May 30 2024
      Business Wire
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      10.040.4459308807138.979.48.823633059.09362079CS
      40.050.5580357142868.969.78.624203129.09190392CS
      12-2-18.165304268811.0111.628.5856050389.53079815CS
      261.2415.95881595887.7716.96.5882890311.90782611CS
      520.718.554216867478.316.94.2655339510.54201809CS
      1560.485.627198124278.5316.92.3628336010.32467409CS
      2600.485.627198124278.5316.92.3628336010.32467409CS

      Market Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      ASLNASLAN Pharmaceuticals Ltd
      $ 2.2511
      (701.10%)
      		16.46k
      CNSPCNS Pharmaceuticals Inc
      $ 2.80
      (122.22%)
      		31.65M
      VVPRVivoPower International PLC
      $ 2.725
      (81.67%)
      		38.5M
      IVPInspire Veterinary Partners Inc
      $ 2.27
      (73.28%)
      		8.13M
      ZCARZoomcar Holdings Inc
      $ 0.2012
      (47.29%)
      		143.67M
      SHPWShapeways Holdings Inc
      $ 0.2812
      (-60.17%)
      		1.33M
      VIVKVivakor Inc
      $ 2.55
      (-24.56%)
      		117.72k
      GMMGlobal Mofy Metaverse Ltd
      $ 0.73
      (-17.05%)
      		806.3k
      SNTISenti Biosciences Inc
      $ 0.324301
      (-16.85%)
      		901.02k
      STISolidion Technology Inc
      $ 0.3981
      (-15.60%)
      		2.15M
      ZCARZoomcar Holdings Inc
      $ 0.2001
      (46.49%)
      		143.66M
      MAXNMaxeon Solar Technologies Ltd
      $ 0.2031
      (12.90%)
      		85.71M
      TSLATesla Inc
      $ 238.45
      (3.11%)
      		38.72M
      VVPRVivoPower International PLC
      $ 2.725
      (81.67%)
      		38.5M
      SMXSMX Security Matters Public Company
      $ 0.137
      (16.79%)
      		36.56M

      ATXS Discussion

      View Posts
      Monksdream Monksdream 2 months ago
      ATXS under $10
      👍️0
      GreenStockEVs GreenStockEVs 11 months ago
      NEWS OUT - Astria Therapeutics Receives Fast Track Designation for STAR-0215 for the Treatment of Hereditary Angioedema

      About Astria Therapeutics:

      Astria Therapeutics is a biopharmaceutical company, and our mission is to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases. Our lead program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in clinical development for the treatment of hereditary angioedema. Learn more about our company on our website, www.astriatx.com.
      👍️0

      Your Recent History

      NASDAQ
      ATXS
      Astria Therapeutics
      BIT
      NSCITA1G0EN2
      European Financial Stabi...
      ASX
      SI6NE
      Si6 Metals
      BIT
      S31938
      Societe Generale Effekten
      AMEX
      WUCT
      ETRACS Whitney US Critic...
      EU
      ALFBA
      Fashion B Air
      Delayed Upgrade Clock